Financial Enhancement Group LLC Viatris Inc Transaction History

Financial Enhancement Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	BUY	$12.09 - $14.68 $314 - $381	26 New	26 $0
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $1,608 - $2,002	-124 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $570 - $778	-42 Reduced 25.3%	124 $2,000
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $2,373 - $3,110	166 New	166 $3,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.